We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Global Clinical Chemistry Analyzers Market to Reach USD 15.97 Billion by 2028

By LabMedica International staff writers
Posted on 11 Jun 2021
The global clinical chemistry analyzers market is projected to grow at a CAGR of 4.25% from USD 11.45 billion in 2020 to USD 15.97 billion by 2028, driven by growth in technology, rising global population, technological improvements in point of care testing devices, and development of laboratory automation.

These are the latest findings of Verified Market Research (Lewes, Delaware, USA), a global research and consulting firm.

The increasing incidences of chronic diseases triggered largely due to lifestyle changes have been a key growth driver of the clinical chemistry analyzers market. More...
A number of tests are carried out for the diagnosis of such diseases that gives a physician important insights into renal, cardiac and liver functions, among others. Thus, the growing prevalence of chronic diseases, especially diabetes, is expected to significantly contribute to the growth of the clinical chemistry analyzers market.

Another key growth driver of the clinical chemistry analyzers market is the rise in geriatric population around the world. The high geriatric population makes it vulnerable to contracting numerous age-associated chronic diseases that require efficient diagnosis, thus leading to the growth of the global clinical chemistry analyzers market.

However, COVID-19 has had a negative impact on the clinical chemistry analyzers market. Due to the ongoing lockdowns, people have been forced to stay indoors, and this restricted movement has slowed down the pace of testing, hence hampering market growth. Additionally, high initial setup costs and shortage of skilled laboratory technicians create further expenses for maintenance of equipment, which further hinders market growth. Nevertheless, increasing government support in the area of diagnostics, coupled with technological advancements, will provide further growth opportunities in the global clinical chemistry analyzers market.

Geographically, North America holds the highest share of the global clinical chemistry analyzers market and is expected to maintain its dominant position throughout the forecast period due to the presence of globally leading market players, technological leadership and an established healthcare infrastructure in the region. The Asia Pacific region is expected to register the highest CAGR in the forecast period, with countries such as China and Japan increasing their expenditure on healthcare facilities. This, coupled with a growing geriatric population and rapid technological growth, will be the key growth drivers of the clinical chemistry analyzers market in Asia Pacific.

Related Links:
Verified Market Research


Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Serological Pipet Controller
PIPETBOY GENIUS
New
Automated Microscope
dIFine
New
Legionella Pneumophila Test
CHORUS Legionella Urinary Antigen
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: A simple blood test could replace surgical biopsies for early detecion of heart transplant rejection (Photo courtesy of Shutterstock)

Blood Test Detects Organ Rejection in Heart Transplant Patients

Following a heart transplant, patients are required to undergo surgical biopsies so that physicians can assess the possibility of organ rejection. Rejection happens when the recipient’s immune system identifies... Read more

Pathology

view channel
These images illustrate how precision oncology Organ Chips recapitulate individual patients’ responses to chemotherapy (Photo courtesy of Wyss Institute at Harvard University)

Cancer Chip Accurately Predicts Patient-Specific Chemotherapy Response

Esophageal adenocarcinoma (EAC), one of the two primary types of esophageal cancer, ranks as the sixth leading cause of cancer-related deaths worldwide and currently lacks effective targeted therapies.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.